Latest & greatest articles for aids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on aids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on aids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for aids

101. Effectiveness of self-administered decision aids for people invited to participate in colorectal cancer screening: a systematic review protocol. (PubMed)

Effectiveness of self-administered decision aids for people invited to participate in colorectal cancer screening: a systematic review protocol. The objective is to assess the effectiveness of self-administered decision aids for people invited to participate in colorectal cancer screening. We will evaluate effects on informed choice, decisional conflict, knowledge, and participation in colorectal cancer screening.

2017 JBI database of systematic reviews and implementation reports

102. Computer-Aided Systematic Review Screening Comes of Age. (PubMed)

Computer-Aided Systematic Review Screening Comes of Age. 28605802 2017 12 11 2018 12 02 1539-3704 167 3 2017 08 01 Annals of internal medicine Ann. Intern. Med. Computer-Aided Systematic Review Screening Comes of Age. 210-211 10.7326/M17-1295 Hemens Brian J BJ From McMaster University, Hamilton, Ontario, Canada. Iorio Alfonso A From McMaster University, Hamilton, Ontario, Canada. eng Journal Article Comment 2017 06 13 United States Ann Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2017

2017 Annals of Internal Medicine

103. The Use of Transdermal Buprenorphine Patches in Aiding in Opioid Withdrawal: Clinical Effectiveness and Guidelines

The Use of Transdermal Buprenorphine Patches in Aiding in Opioid Withdrawal: Clinical Effectiveness and Guidelines The Use of Transdermal Buprenorphine Patches in Aiding in Opioid Withdrawal: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need The Use of Transdermal Buprenorphine Patches in Aiding in Opioid Withdrawal: Clinical Effectiveness and Guidelines The Use of Transdermal Buprenorphine Patches in Aiding in Opioid Withdrawal: Clinical Effectiveness (...) and Guidelines Published on: June 8, 2017 Project Number: RA0911-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What is the clinical effectiveness regarding the use of buprenorphine patches for aiding in opioid withdrawal prior to starting a patient on buprenorphine/naloxone? What are the evidence-based guidelines regarding the use of buprenorphine patches for aiding in opioid withdrawal prior to starting a patient on buprenorphine/naloxone? Key Message One non

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

104. Effect of Combined Patient Decision Aid and Patient Navigation vs Usual Care for Colorectal Cancer Screening in a Vulnerable Patient Population: A Randomized Clinical Trial

Effect of Combined Patient Decision Aid and Patient Navigation vs Usual Care for Colorectal Cancer Screening in a Vulnerable Patient Population: A Randomized Clinical Trial Colorectal cancer (CRC) screening is underused, especially among vulnerable populations. Decision aids and patient navigation are potentially complementary interventions for improving CRC screening rates, but their combined effect on screening completion is unknown.To determine the combined effect of a CRC screening decision (...) aid and patient navigation compared with usual care on CRC screening completion.In this randomized clinical trial, data were collected from January 2014 to March 2016 at 2 community health center practices, 1 in North Carolina and 1 in New Mexico, serving vulnerable populations. Patients ages 50 to 75 years who had average CRC risk, spoke English or Spanish, were not current with recommended CRC screening, and were attending primary care visits were recruited and randomized 1:1 to intervention

Full Text available with Trip Pro

2017 EvidenceUpdates

105. Decision aids for people facing health treatment or screening decisions. (PubMed)

Decision aids for people facing health treatment or screening decisions. Decision aids are interventions that support patients by making their decisions explicit, providing information about options and associated benefits/harms, and helping clarify congruence between decisions and personal values.To assess the effects of decision aids in people facing treatment or screening decisions.Updated search (2012 to April 2015) in CENTRAL; MEDLINE; Embase; PsycINFO; and grey literature; includes CINAHL (...) to September 2008.We included published randomized controlled trials comparing decision aids to usual care and/or alternative interventions. For this update, we excluded studies comparing detailed versus simple decision aids.Two reviewers independently screened citations for inclusion, extracted data, and assessed risk of bias. Primary outcomes, based on the International Patient Decision Aid Standards (IPDAS), were attributes related to the choice made and the decision-making process.Secondary outcomes

Full Text available with Trip Pro

2017 Cochrane

106. Aid effectiveness and programmatic effectiveness: a proposed framework for comparative evaluation of different aid interventions in a particular health system (PubMed)

Aid effectiveness and programmatic effectiveness: a proposed framework for comparative evaluation of different aid interventions in a particular health system Against a backdrop of changing concepts of aid effectiveness, development effectiveness, health systems strengthening, and increasing emphasis on impact evaluation, this article proposes a theory-driven impact evaluation framework to gauge the effect of aid effectiveness principles on programmatic outcomes of different aid funded programs (...) in the health sector of a particular country.The foundation and step-by-step process of implementing the framework are described.With empirical evidence from the field, the steps involve analysis of context, program designs, implementation mechanisms, outcomes, synthesis, and interpretation of findings through the programs' underlying program theories and interactions with the state context and health system.The framework can be useful for comparatively evaluating different aid interventions both in fragile

Full Text available with Trip Pro

2017 Global health research and policy

107. UNAIDS 90–90–90 targets to end the AIDS epidemic by 2020 are not realistic: comment on “Can the UNAIDS 90–90–90 target be achieved? A systematic analysis of national HIV treatment cascades” (PubMed)

UNAIDS 90–90–90 targets to end the AIDS epidemic by 2020 are not realistic: comment on “Can the UNAIDS 90–90–90 target be achieved? A systematic analysis of national HIV treatment cascades” 28589026 2018 11 13 2059-7908 2 2 2017 BMJ global health BMJ Glob Health UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on "Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades". e000227 10.1136/bmjgh-2016-000227 (...) 101685275 2059-7908 Competing interests: None declared. 2016 10 29 2017 01 03 2017 01 06 2017 6 8 6 0 2017 6 8 6 0 2017 6 8 6 1 epublish 28589026 10.1136/bmjgh-2016-000227 bmjgh-2016-000227 PMC5435269 BMC Public Health. 2016 Sep 21;16(1):1002 27655406 PLoS One. 2016 Jun 07;11(6):e0156619 27272890 Lancet. 2014 Jul 19;384(9939):258-71 24907868 AIDS Care. 2017 Mar;29(3):326-334 27539782 J Int AIDS Soc. 2015 Jul 23;18:20090 26208630 Trop Med Int Health. 2016 Feb;21(2):219-23 26584666 J Med Ethics. 2014 Jul

Full Text available with Trip Pro

2017 BMJ global health

108. Foundation and methodologies in computer-aided diagnosis systems for breast cancer detection (PubMed)

Foundation and methodologies in computer-aided diagnosis systems for breast cancer detection Breast cancer is the most prevalent cancer that affects women all over the world. Early detection and treatment of breast cancer could decline the mortality rate. Some issues such as technical reasons, which related to imaging quality and human error, increase misdiagnosis of breast cancer by radiologists. Computer-aided detection systems (CADs) are developed to overcome these restrictions and have been

Full Text available with Trip Pro

2017 EXCLI journal

109. Dental Students Can Benefit by Starting to Learn Indirect Vision (Mirror) Skills Early in Preclinical Studies with The Aid of a Training Device

Dental Students Can Benefit by Starting to Learn Indirect Vision (Mirror) Skills Early in Preclinical Studies with The Aid of a Training Device UTCAT3133, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Dental Students Can Benefit by Starting to Learn Indirect Vision (Mirror) Skills Early in Preclinical Studies with The Aid of a Training Device Clinical Question In dental students, does use of a training device lead

2017 UTHSCSA Dental School CAT Library

110. Strategies for improving the lives of women aged 40 and above living with HIV/AIDS.

Strategies for improving the lives of women aged 40 and above living with HIV/AIDS. Strategies for improving the lives of women aged 40 and above living with HIV/AIDS. Strategies for improving the lives of women aged 40 and above living with HIV/AIDS. Adam GP, Di M, Cu-Uvin S, Halladay C, Smith BT, Trikalinos TA Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Adam GP, Di M, Cu-Uvin S, Halladay C, Smith BT, Trikalinos TA. Strategies for improving the lives of women aged 40 and above living with HIV/AIDS. Rockville: Agency for Healthcare Research and Quality (AHRQ). Technical Brief No. 29. 2016 Authors' objectives While in its early years the HIV epidemic affected primarily the male and the young, nowadays the population living with HIV/AIDS comprises approximately 24 percent women, and its age composition has shifted towards older

2017 Health Technology Assessment (HTA) Database.

111. Assessing and Refining Myocardial Infarction Risk Estimation among Patients with Human Immunodeficiency Virus: Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) (PubMed)

Assessing and Refining Myocardial Infarction Risk Estimation among Patients with Human Immunodeficiency Virus: Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Persons with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved longevity but face an elevated risk of myocardial infarction (MI) due to common MI risk factors and HIV-specific factors. Despite these elevated MI rates, optimal methods to predict MI risks for HIV-infected (...) persons remain unclear.To determine the extent to which existing and de novo estimation tools predict MI in a multicenter HIV cohort with rigorous MI adjudication.We evaluated the performance of standard of care and 2 new data-derived MI risk estimation models in 5 Centers for AIDS Research Network of Integrated Clinical Systems sites across the United States where a multicenter clinical prospective cohort of 19 829 HIV-infected adults received care in inpatient and outpatient settings since 1995

Full Text available with Trip Pro

2017 JAMA cardiology

112. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance. (PubMed)

Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance. In this report we assess who pays for cooperation in global health through an analysis of the financial flows of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, TB and Malaria, and Gavi, the Vaccine Alliance. The past few decades have seen the consolidation of influence in the disproportionate roles the USA

Full Text available with Trip Pro

2017 Lancet

113. Taking the health aid debate to the subnational level: the impact and allocation of foreign health aid in Malawi (PubMed)

Taking the health aid debate to the subnational level: the impact and allocation of foreign health aid in Malawi Cross-national studies provide inconclusive results as to the effectiveness of foreign health aid. We highlight a novel application of using subnational data to evaluate aid impacts, using Malawi as a case study.We employ two rounds of nationally representative household surveys (2004/2005 and 2010/2011) and geo-referenced foreign aid data. We examine the determinants of Malawi's (...) traditional authorities receiving aid according to health, environmental risk, socioeconomic and political factors. We use two approaches to estimate the impact of aid on reducing malaria prevalence and increasing healthcare quality: difference-in-difference models, which include traditional authority and month-of-interview fixed effects and control for individual and household level time-varying factors, and entropy balancing, where models balance on health-related and socioeconomic baseline

Full Text available with Trip Pro

2017 BMJ global health

114. Preferred profile for hearing-aid technology suitable for low- and middle-income countries

Preferred profile for hearing-aid technology suitable for low- and middle-income countries Preferred profile for hearing-aid technology suitable for low- and middle-income countries JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Preferred profile for hearing-aid technology suitable for low- and middle-income countries View/ Open Rights View Statistics Altmetrics Share (...) Citation World Health Organization . (‎2017)‎. Preferred profile for hearing-aid technology suitable for low- and middle-income countries. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description xii, 16 p. ISBN 9789241512961 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ 2015 )‎  Executive Board, 77 (‎ EB77/16 , 1985 )‎  World Health Organization (‎ 1994 )‎ View Item

2017 WHO

115. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid (...) to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis Frampton G K, Jones J, Rose M & Payne L Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Frampton G K, Jones J, Rose M & Payne L. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women

2017 Health Technology Assessment (HTA) Database.

116. HIV/AIDS: Framework for action in the who African Region, 2016 - 2020

HIV/AIDS: Framework for action in the who African Region, 2016 - 2020 End HIV/AIDS by 2030: Framework for action in the WHO African Region, 2016 - 2020 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links End HIV/AIDS by 2030: Framework for action in the WHO African Region, 2016 - 2020 View/ Open View Statistics Altmetrics Share Other Titles HIV/AIDS: Framework for action (...) in the WHO African Region, 2016 - 2020 Health Plan Implementation Citation World Health Organization. Regional Office for Africa . (‎2017)‎. End HIV/AIDS by 2030: Framework for action in the WHO African Region, 2016 - 2020. World Health Organization. Regional Office for Africa. Description v, 13 p. Other Language Versions Collections Language English Metadata View Item

2017 WHO

117. Determinants of Voluntary HIV/AIDS Counseling and Testing among Community College Students in the United States (PubMed)

Determinants of Voluntary HIV/AIDS Counseling and Testing among Community College Students in the United States Human Immunodeficiency Virus (HIV) testing remains the best public health preventive strategy in the fight against HIV/AIDS. We assessed the factors that determined voluntary counseling and screening/testing for HIV among college students.In this cross-sectional study, a purposeful sample of 189 college students was analyzed using three health belief model (HBM) variables

Full Text available with Trip Pro

2017 International journal of MCH and AIDS

118. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. (PubMed)

Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Rapid progression to AIDS after acute HIV-1 infection, though uncommon, has been noted, as has the transmission of multidrug resistant viruses. Here, we describe a patient in whom these two factors arose concomitantly and assess the effects.We did a case study of a patient with HIV-1 seroconversion. We genotyped the virus and host genetic markers by PCR and nucleotide sequencing. To ascertain (...) the drug susceptibility of our patient's HIV-1 we did phenotypic studies with the PhenoSense assay. We assessed viral coreceptor use via syncytium formation in vitro and with a modified PhenoSense assay.Our patient seems to have been recently infected by a viral variant of HIV-1 resistant to multiple classes of antiretroviral drugs. Furthermore, his virus population is dual tropic for cells that express CCR5 or CXCR4 coreceptor. The infection has resulted in progression to symptomatic AIDS in 4-20

2017 Lancet

119. In elderly patients with ankle fractures who are unable to safely mobilise non-weight bearing using appropriate walking aids; does allowing partial weight bearing of the affected leg reduce the length of time spent in hospital, reduce complications of bed

In elderly patients with ankle fractures who are unable to safely mobilise non-weight bearing using appropriate walking aids; does allowing partial weight bearing of the affected leg reduce the length of time spent in hospital, reduce complications of bed Getting Evidence into Clinical Practice: Musculoskeletal Research Facilitation Group (CAT Group) Date: December 2017 Date CAT completed December 2017 Date for review December 2022 CAT leads Jennifer Hamblin Jennifer.Hamblin@nhs.net Katie Wills (...) of walking aids) for 6 weeks. For those patients who are unable to mobilise in this way, non-ambulatory care is required. Non-ambulatory care results in increased time spent in bed, this is a problem because bed-rest is associated with complications such as increased frailty and mortality. In the six week period before functional rehabilitation can begin patients either remain in an acute hospital bed or will often be moved to temporary care in non-acute settings in the community. In either setting

2017 Public Health England

120. Monitoring and evaluation of sport-based HIV/AIDS awareness programmes: Strengthening outcome indicators (PubMed)

Monitoring and evaluation of sport-based HIV/AIDS awareness programmes: Strengthening outcome indicators There are number of Non-Governmental Organisations (NGOs) in South Africa that use sport as a tool to respond to Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), however, little is reported about the outcomes and impact of these programmes. The aim of this study is to contribute to a generic monitoring and evaluation framework by improving the options for the use (...) of outcome indicators of sport-based HIV/AIDS awareness programmes of selected NGOs in South Africa. A qualitative method study was carried out with seven employees of five selected NGOs that integrate sport to deliver HIV/AIDS programmes in South Africa. The study further involved six specialists/experts involved in the field of HIV/AIDS and an official from Sport Recreation South Africa (SRSA). Multiple data collection instruments including desktop review, narrative systematic review, document analysis

Full Text available with Trip Pro

2016 SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance